Autoimmune Disorders

Immunology·MeSH: Autoimmune Diseases

13 drugs in development·9 companies·2 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
autoimmune analyzer	Quest Diagnostics Incorporated (DGX)
Cortrophin Gel	ANI PHARMACEUTICALS INC (ANIP)
Purified Cortrophin Gel	ANI PHARMACEUTICALS INC (ANIP)

Phase 1(2)

Drug	Company
Azer-cel	TG THERAPEUTICS, INC. (TGTX)
Azercabtagene zapreleucel	TG THERAPEUTICS, INC. (TGTX)

Preclinical(7)

Drug	Company
AZD1656	CDT Equity Inc. (CDT)
AZD5658	CDT Equity Inc. (CDT)
gtb-7550	GT Biopharma, Inc. (GTBP)
il-2 ai synthorin	Synthorx, Inc. (THOR)
small molecule nr2f6 modulators	Regen BioPharma Inc (RGBPP)
vadc45	Vor Biopharma Inc. (VOR)
vx5	VACCINEX, INC. (VCNX)

Unknown(1)

Drug	Company
AZD1656 Cocrystal	CDT Equity Inc. (CDT)

BioSniper tracks 13 drugs in development for Autoimmune Disorders across 9 companies.

There are 2 clinical trials targeting Autoimmune Disorders tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.